Rab 2A Inhibitors belong to a specific chemical class designed to modulate cellular processes by targeting the Rab GTPase family, particularly Rab 2A. The Rab GTPases, critical components of intracellular vesicular trafficking, play a fundamental role in regulating the transport of cellular cargo between various membrane-bound compartments. Among these, Rab 2A is implicated in the early secretory pathway, where it facilitates the movement of vesicles from the endoplasmic reticulum to the Golgi apparatus. The development of Rab 2A Inhibitors stems from the recognition of the pivotal role of Rab 2A in orchestrating these intricate cellular mechanisms.
Rab 2A Inhibitors are meticulously designed molecules that interact with the Rab 2A protein, impeding its GTPase activity. By disrupting the GTPase cycle, these inhibitors effectively modulate the activation state of Rab 2A, leading to alterations in vesicle trafficking dynamics. Consequently, this modulation influences crucial cellular processes, including protein sorting, membrane fusion, and organelle homeostasis. The detailed understanding of the molecular interactions between Rab 2A Inhibitors and their target provides valuable insights into the intricacies of intracellular transport, offering a platform for further exploration of cellular physiology and potential applications in diverse scientific disciplines.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
This inhibitor blocks the enzyme geranylgeranyltransferase, which is responsible for the post-translational modification of Rab 2A necessary for its activity. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
This compound disrupts the structure and function of the Golgi apparatus, thereby affecting vesicle trafficking processes mediated by Rab 2A. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
As an ionophore that disrupts Golgi function, monensin can indirectly affect Rab 2A's role in vesicle transport. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
This small molecule inhibitor of dynamin interferes with the fission of vesicles from the Golgi, where Rab 2A operates. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibiting cytohesins with SecinH3 affects ARF family GTPases and indirectly alters the functionality of Rab 2A in cellular trafficking. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
As a selective inhibitor of Cdc42, ML141 indirectly affects vesicle formation and trafficking pathways involving Rab 2A. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
By inhibiting GSK-3, lithium chloride indirectly modulates various signaling pathways, potentially influencing Rab 2A's associated functions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
This PI3 kinase inhibitor can modulate intracellular signaling pathways, indirectly affecting Rab 2A's role in vesicle trafficking. | ||||||